References

  1. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1–33.
  2. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012; 3: 107.
  3. Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005; 100: 1345–53.
  4. Castaño-Milla C, Chaparro M, Gisbert JP. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014; 39: 645–59.
  5. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526–35.
  6. Sebastian S, Hernández V, Myrelid P, et al. Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 2014; 8: 5–18.
  7. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal Cancer and Inflammatory Bowel Disease: Epidemiology, Risk Factors, Mechanisms of Carcinogenesis and Prevention Strategies. Anticancer Res 2009; 29: 2727–37.
  8. Velayos FS, Loftus EV, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006; 130: 1941–9.
  9. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982–1018.
  10. Connor A, Tolan D, Hughes S, Carr N, Tomson C. Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents. Gut 2012; 61: 1525–32.
  11. TNM and number stages of bowel cancer | Cancer Research UK. http://www.cancerresearchuk.org/about-cancer/type/bowel-cancer/treatment... (accessed March 3, 2015).
  12. Cancer of the Colon and Rectum - SEER Stat Fact Sheets. http://seer.cancer.gov/statfacts/html/colorect.html (accessed March 3, 2015).
  13. Brenner H, Bouvier AM, Foschi R, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study. Int J Cancer J Int Cancer 2012; 131: 1649–58.
  14. Cohen AB et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013 May;58(5):1322-8.
  15. Hou JK et al. Review of Patient-Targeted Recommendations. Clin Gastroenterol Hepatol. 2014;12(10):1592-1600. 
  16. Olendzki BC et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutrition Journal 2014 13:5 DOI: 10.1186/1475-2891-13-5. Available online at: https://nutritionj.biomedcentral.com/articles/10.1186/1475-2891-13-5. Accessed 17 October 2016.
  17. Marlow G et al. Food Intolerance: Associations with the rs12212067 Polymorphism of FOXO3 in Crohn's Disease Patients in New Zealand. J Nutrigenet Nutrigenomics 2015;8:70-80 (DOI:10.1159/000435783). Available at: https://www.karger.com/Article/FullText/435783. Accessed 17 October 2016.

Rate this content

No votes yet

Feedback Form